Accuray Inc (ARAY)

$0.25 0.00 (-1.77%)
Market Cap 30.32M
Revenue (ttm) 458.51M
Net Income (ttm) -1.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -0.35%
Debt to Equity Ratio 3.21
Volume 2,297,900
Avg Vol 3,938,172
Day's Range N/A - N/A
Shares Out 118.96M
Stochastic %K 7%
Beta 1.39
Analysts Hold
Price Target $0.35

Company Profile

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tu...

Industry: Medical Devices
Sector: Healthcare
Phone: 608 824 2800
Fax: 608 824 2996
Address:
1240 Deming Way, Madison, United States
Sammy2425
Sammy2425 Jul. 2 at 1:59 PM
$ARAY wake Me at volume 10 mill and price over 1.00
0 · Reply
Sammy2425
Sammy2425 Jul. 2 at 1:52 PM
$ARAY we’ve seen nothing yet!
0 · Reply
Jestep
Jestep Jul. 1 at 9:17 PM
$ARAY wild after 2M shares during the day there’s been zero shares traded after hours…
0 · Reply
Sammy2425
Sammy2425 Jul. 1 at 5:19 PM
$ARAY nice volume!!
0 · Reply
goldenmanchurian
goldenmanchurian Jun. 30 at 8:15 PM
$ARAY whoever senior management members made the business decision to form joint venture in china and let the chinese steal the technology and mass produce the bootlegged products, should be sued and put in jail. They obviously had no idea about china, and mades horrible decisions to destroy the company in long run..
0 · Reply
Sammy2425
Sammy2425 Jun. 29 at 3:46 PM
$ARAY at this pace she won’t make it to Aug 3
0 · Reply
Sammy2425
Sammy2425 Jun. 29 at 3:45 PM
$ARAY almost 3 mill shares saying the “hell with this shit”. Better to take a quarter then a dime
0 · Reply
Sammy2425
Sammy2425 Jun. 29 at 1:54 PM
$ARAY nice volume Flush
0 · Reply
Sammy2425
Sammy2425 Jun. 29 at 1:28 PM
$ARAY next stop .17
0 · Reply
Sammy2425
Sammy2425 Jun. 29 at 12:21 PM
$ARAY .10 for a pop not a penny more .002-.02
0 · Reply
Latest News on ARAY
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

May 29, 2026, 4:10 PM EDT - 5 weeks ago

Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer

May 15, 2026, 4:05 PM EDT - 7 weeks ago

Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer

Accuray downgraded to Hold from Buy at Jefferies

2026-05-12T09:10:10.000Z - 7 weeks ago

Accuray downgraded to Hold from Buy at Jefferies

Accuray downgraded to Neutral from Buy at BTIG

2026-05-07T11:42:52.000Z - 2 months ago

Accuray downgraded to Neutral from Buy at BTIG

Accuray reports Q3 EPS (9c) vs. (1c) last year

2026-05-07T01:32:39.000Z - 2 months ago

Accuray reports Q3 EPS (9c) vs. (1c) last year

Accuray Earnings Call Transcript: Q3 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

Accuray Earnings Call Transcript: Q3 2026

Accuray Earnings release: Q3 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

Accuray Earnings release: Q3 2026

Accuray Quarterly report: Q3 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

Accuray Quarterly report: Q3 2026

Accuray Slides: Q3 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

Accuray Slides: Q3 2026

Accuray Reports Fiscal 2026 Third Quarter Financial Results

May 6, 2026, 4:05 PM EDT - 2 months ago

Accuray Reports Fiscal 2026 Third Quarter Financial Results

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Apr 22, 2026, 4:05 PM EDT - 2 months ago

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Accuray names Paul Miele as Chief Commercial Officer

2026-04-06T13:22:58.000Z - 3 months ago

Accuray names Paul Miele as Chief Commercial Officer

Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer

Apr 6, 2026, 9:00 AM EDT - 3 months ago

Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer

Accuray files to sell 7M shares of common stock for holders

2026-02-17T21:31:56.000Z - 4 months ago

Accuray files to sell 7M shares of common stock for holders

Accuray Registration statement: Registration Filing

Feb 17, 2026, 7:00 AM EST - 4 months ago

Accuray Registration statement: Registration Filing

Accuray price target lowered to $2 from $4 at BTIG

2026-02-05T12:20:14.000Z - 5 months ago

Accuray price target lowered to $2 from $4 at BTIG

Accuray Earnings Call Transcript: Q2 2026

Feb 4, 2026, 4:30 PM EST - 5 months ago

Accuray Earnings Call Transcript: Q2 2026

Accuray Quarterly report: Q2 2026

Feb 4, 2026, 4:30 PM EST - 5 months ago

Accuray Quarterly report: Q2 2026

Accuray Earnings release: Q2 2026

Feb 4, 2026, 4:30 PM EST - 5 months ago

Accuray Earnings release: Q2 2026

Accuray Slides: Q2 2026

Feb 4, 2026, 4:30 PM EST - 5 months ago

Accuray Slides: Q2 2026

Accuray sees FY26 revenue $440M-$450M

2026-02-04T21:17:14.000Z - 5 months ago

Accuray sees FY26 revenue $440M-$450M

Accuray reports Q2 EPS (11c) vs. 2c last year

2026-02-04T21:10:20.000Z - 5 months ago

Accuray reports Q2 EPS (11c) vs. 2c last year

Accuray Reports Fiscal 2026 Second Quarter Financial Results

Feb 4, 2026, 4:05 PM EST - 5 months ago

Accuray Reports Fiscal 2026 Second Quarter Financial Results

Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026

Jan 21, 2026, 4:05 PM EST - 5 months ago

Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026

Accuray to reduce headcount by 15%, outsource non-core activities

2025-12-15T22:05:09.000Z - 7 months ago

Accuray to reduce headcount by 15%, outsource non-core activities

Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth

Dec 15, 2025, 5:00 PM EST - 7 months ago

Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth

Accuray Earnings Call Transcript: Q1 2026

Nov 5, 2025, 4:30 PM EST - 8 months ago

Accuray Earnings Call Transcript: Q1 2026

Accuray Earnings release: Q1 2026

Nov 5, 2025, 4:30 PM EST - 8 months ago

Accuray Earnings release: Q1 2026

Accuray Quarterly report: Q1 2026

Nov 5, 2025, 4:30 PM EST - 8 months ago

Accuray Quarterly report: Q1 2026

Accuray Slides: Q1 2026

Nov 5, 2025, 4:30 PM EST - 8 months ago

Accuray Slides: Q1 2026

Accuray reports Q1 EPS (18c) vs (4c) last year

2025-11-05T21:22:44.000Z - 8 months ago

Accuray reports Q1 EPS (18c) vs (4c) last year

Accuray Reports Fiscal 2026 First Quarter Financial Results

Nov 5, 2025, 4:05 PM EST - 8 months ago

Accuray Reports Fiscal 2026 First Quarter Financial Results

Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025

Oct 28, 2025, 7:35 AM EDT - 8 months ago

Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025

Accuray sees Q1 revenue $92.5M-$94M, consensus $91.35M

2025-10-20T13:30:30.000Z - 9 months ago

Accuray sees Q1 revenue $92.5M-$94M, consensus $91.35M

Accuray appoints Steve La Neve as CEO

2025-10-20T13:25:17.000Z - 9 months ago

Accuray appoints Steve La Neve as CEO

Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth

Oct 20, 2025, 9:20 AM EDT - 9 months ago

Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth

Accuray Proxy statement: Proxy Filing

Oct 20, 2025, 8:00 AM EDT - 9 months ago

Accuray Proxy statement: Proxy Filing

Accuray announces first patient treated in Melbourne with CyberKnife S7 System

2025-10-08T11:45:18.000Z - 9 months ago

Accuray announces first patient treated in Melbourne with CyberKnife S7 System

Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System

Oct 8, 2025, 7:35 AM EDT - 9 months ago

Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System

Accuray Proxy statement: Proxy Filing

Oct 1, 2025, 8:00 AM EDT - 9 months ago

Accuray Proxy statement: Proxy Filing

Accuray Proxy statement: Proxy Filing

Oct 1, 2025, 8:00 AM EDT - 9 months ago

Accuray Proxy statement: Proxy Filing

Accuray, University of Wisconsin-Madison sign memorandum of understanding

2025-09-30T11:40:23.000Z - 9 months ago

Accuray, University of Wisconsin-Madison sign memorandum of understanding

Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care

Sep 30, 2025, 7:35 AM EDT - 9 months ago

Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care

Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care

Sep 26, 2025, 7:35 AM EDT - 10 months ago

Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care

Accuray to Host Analyst Event at the American Society of Radiation Oncology Meeting on September 29, 2025

Sep 11, 2025, 4:10 PM EDT - 10 months ago

Accuray to Host Analyst Event at the American Society of Radiation Oncology Meeting on September 29, 2025

Accuray price target raised to $5 from $4 at BTIG

2025-08-14T11:26:17.000Z - 11 months ago

Accuray price target raised to $5 from $4 at BTIG

Accuray Earnings Call Transcript: Q4 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

Accuray Earnings Call Transcript: Q4 2025

Accuray Annual report: Q4 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

Accuray Annual report: Q4 2025

Accuray Earnings release: Q4 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

Accuray Earnings release: Q4 2025

Accuray Slides: Q4 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

Accuray Slides: Q4 2025

Accuray Sees FY26 revenue $471M-$485M, consensus $445.07M

2025-08-13T20:21:28.000Z - 11 months ago

Accuray Sees FY26 revenue $471M-$485M, consensus $445.07M

Accuray reports Q4 EPS 1c vs. 3c last year

2025-08-13T20:15:23.000Z - 11 months ago

Accuray reports Q4 EPS 1c vs. 3c last year

Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results

Aug 13, 2025, 4:05 PM EDT - 11 months ago

Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results

Accuray to Report Fourth Quarter Fiscal 2025 Financial Results on August 13, 2025

Jul 30, 2025, 4:05 PM EDT - 1 year ago

Accuray to Report Fourth Quarter Fiscal 2025 Financial Results on August 13, 2025

Accuray files to sell 23.43M shares of common stock for holders

2025-07-28T20:17:14.000Z - 1 year ago

Accuray files to sell 23.43M shares of common stock for holders

Accuray Registration statement: Registration Filing

Jul 28, 2025, 8:00 AM EDT - 1 year ago

Accuray Registration statement: Registration Filing

Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities

Jun 6, 2025, 7:30 AM EDT - 1 year ago

Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities

Accuray Transcript: Jefferies Global Healthcare Conference 2025

Jun 4, 2025, 5:30 PM EDT - 1 year ago

Accuray Transcript: Jefferies Global Healthcare Conference 2025

Accuray to Participate in the Jefferies Global Healthcare Conference 2025

May 29, 2025, 7:30 PM EDT - 1 year ago

Accuray to Participate in the Jefferies Global Healthcare Conference 2025

Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025

May 7, 2025, 7:35 AM EDT - 1 year ago

Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025

Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System

May 5, 2025, 4:10 PM EDT - 1 year ago

Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System

Accuray Earnings Call Transcript: Q3 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Accuray Earnings Call Transcript: Q3 2025

Accuray Quarterly report: Q3 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Accuray Quarterly report: Q3 2025

Accuray Earnings release: Q3 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Accuray Earnings release: Q3 2025

Accuray Slides: Q3 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Accuray Slides: Q3 2025

Accuray Reports Fiscal 2025 Third Quarter Financial Results

Apr 30, 2025, 4:05 PM EDT - 1 year ago

Accuray Reports Fiscal 2025 Third Quarter Financial Results

Accuray CyberKnife® Platform Featured in New Studies Showcasing its Benefits in Central Nervous System Tumors Presented at Radiosurgery Society Scientific Meeting

Apr 3, 2025, 7:35 AM EDT - 1 year ago

Accuray CyberKnife® Platform Featured in New Studies Showcasing its Benefits in Central Nervous System Tumors Presented at Radiosurgery Society Scientific Meeting

Accuray to Participate at 37th Annual Roth Conference

Mar 12, 2025, 7:30 AM EDT - 1 year ago

Accuray to Participate at 37th Annual Roth Conference

Accuray Earnings Call Transcript: Q2 2025

Feb 5, 2025, 4:30 PM EST - 1 year ago

Accuray Earnings Call Transcript: Q2 2025

Accuray Earnings release: Q2 2025

Feb 5, 2025, 4:30 PM EST - 1 year ago

Accuray Earnings release: Q2 2025

Accuray Quarterly report: Q2 2025

Feb 5, 2025, 4:30 PM EST - 1 year ago

Accuray Quarterly report: Q2 2025

Accuray Slides: Q2 2025

Feb 5, 2025, 4:30 PM EST - 1 year ago

Accuray Slides: Q2 2025

Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance

Feb 5, 2025, 4:05 PM EST - 1 year ago

Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product

Jan 23, 2025, 7:35 AM EST - 1 year ago

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product

Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025

Jan 22, 2025, 4:05 PM EST - 1 year ago

Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025

Leonel Peralta to Join Accuray as Chief Operations Officer

Jan 21, 2025, 9:15 AM EST - 1 year ago

Leonel Peralta to Join Accuray as Chief Operations Officer

Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C System

Jan 13, 2025, 3:00 PM EST - 1 year ago

Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C System

New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat

Dec 18, 2024, 7:35 AM EST - 1 year ago

New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat

Accuray Earnings Call Transcript: Q1 2025

Nov 6, 2024, 4:30 PM EST - 1 year ago

Accuray Earnings Call Transcript: Q1 2025

Accuray Quarterly report: Q1 2025

Nov 6, 2024, 4:30 PM EST - 1 year ago

Accuray Quarterly report: Q1 2025

Accuray Earnings release: Q1 2025

Nov 6, 2024, 4:30 PM EST - 1 year ago

Accuray Earnings release: Q1 2025

Accuray Slides: Q1 2025

Nov 6, 2024, 4:30 PM EST - 1 year ago

Accuray Slides: Q1 2025

Accuray Reports Fiscal 2025 First Quarter Financial Results

Nov 6, 2024, 4:05 PM EST - 1 year ago

Accuray Reports Fiscal 2025 First Quarter Financial Results

Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024

Oct 23, 2024, 4:05 PM EDT - 1 year ago

Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024

Accuray Appoints Michael Murphy as VP, Corporate Controller

Oct 21, 2024, 4:05 PM EDT - 1 year ago

Accuray Appoints Michael Murphy as VP, Corporate Controller

Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence

Oct 15, 2024, 8:45 AM EDT - 1 year ago

Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence

Accuray Proxy statement: Proxy Filing

Oct 4, 2024, 8:00 AM EDT - 1 year ago

Accuray Proxy statement: Proxy Filing

Accuray Proxy statement: Proxy Filing

Oct 4, 2024, 8:00 AM EDT - 1 year ago

Accuray Proxy statement: Proxy Filing

Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training

Sep 30, 2024, 7:35 AM EDT - 1 year ago

Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training

Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution

Sep 10, 2024, 5:30 PM EDT - 1 year ago

Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution

Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence

Sep 3, 2024, 4:10 PM EDT - 1 year ago

Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence

Accuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix™

Aug 27, 2024, 7:35 AM EDT - 2 years ago

Accuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix™

Accuray Earnings Call Transcript: Q4 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Accuray Earnings Call Transcript: Q4 2024

Accuray Annual report: Q4 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Accuray Annual report: Q4 2024

Accuray Earnings release: Q4 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Accuray Earnings release: Q4 2024

Accuray Slides: Q4 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Accuray Slides: Q4 2024

Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results

Aug 14, 2024, 4:05 PM EDT - 2 years ago

Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results

Halifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact® Radiation Delivery System and VitalHold™ Technology

Aug 13, 2024, 7:35 AM EDT - 2 years ago

Halifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact® Radiation Delivery System and VitalHold™ Technology

Accuray to Report Fourth Quarter Fiscal 2024 Financial Results on August 14, 2024

Jul 31, 2024, 4:05 PM EDT - 2 years ago

Accuray to Report Fourth Quarter Fiscal 2024 Financial Results on August 14, 2024

Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care

Jun 27, 2024, 7:35 AM EDT - 2 years ago

Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care

Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients

Jun 20, 2024, 7:35 AM EDT - 2 years ago

Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients

Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration

Jun 12, 2024, 7:35 AM EDT - 2 years ago

Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration

Accuray Transcript: Jefferies Global Healthcare Conference

Jun 5, 2024, 7:30 AM EDT - 2 years ago

Accuray Transcript: Jefferies Global Healthcare Conference

Accuray to Participate in the Jefferies Global Healthcare Conference 2024

May 22, 2024, 4:30 PM EDT - 2 years ago

Accuray to Participate in the Jefferies Global Healthcare Conference 2024

Accuray Earnings Call Transcript: Q3 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Accuray Earnings Call Transcript: Q3 2024

Accuray Quarterly report: Q3 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Accuray Quarterly report: Q3 2024

Accuray Earnings release: Q3 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Accuray Earnings release: Q3 2024

Accuray Slides: Q3 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Accuray Slides: Q3 2024

Accuray Reports Fiscal 2024 Third Quarter Financial Results

May 1, 2024, 4:06 PM EDT - 2 years ago

Accuray Reports Fiscal 2024 Third Quarter Financial Results

Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024

Apr 25, 2024, 7:35 AM EDT - 2 years ago

Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024

Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland

Apr 18, 2024, 7:35 AM EDT - 2 years ago

Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland

Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024

Apr 17, 2024, 4:05 PM EDT - 2 years ago

Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024

New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System

Mar 26, 2024, 7:35 AM EDT - 2 years ago

New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System

Sammy2425
Sammy2425 Jul. 2 at 1:59 PM
$ARAY wake Me at volume 10 mill and price over 1.00
0 · Reply
Sammy2425
Sammy2425 Jul. 2 at 1:52 PM
$ARAY we’ve seen nothing yet!
0 · Reply
Jestep
Jestep Jul. 1 at 9:17 PM
$ARAY wild after 2M shares during the day there’s been zero shares traded after hours…
0 · Reply
Sammy2425
Sammy2425 Jul. 1 at 5:19 PM
$ARAY nice volume!!
0 · Reply
goldenmanchurian
goldenmanchurian Jun. 30 at 8:15 PM
$ARAY whoever senior management members made the business decision to form joint venture in china and let the chinese steal the technology and mass produce the bootlegged products, should be sued and put in jail. They obviously had no idea about china, and mades horrible decisions to destroy the company in long run..
0 · Reply
Sammy2425
Sammy2425 Jun. 29 at 3:46 PM
$ARAY at this pace she won’t make it to Aug 3
0 · Reply
Sammy2425
Sammy2425 Jun. 29 at 3:45 PM
$ARAY almost 3 mill shares saying the “hell with this shit”. Better to take a quarter then a dime
0 · Reply
Sammy2425
Sammy2425 Jun. 29 at 1:54 PM
$ARAY nice volume Flush
0 · Reply
Sammy2425
Sammy2425 Jun. 29 at 1:28 PM
$ARAY next stop .17
0 · Reply
Sammy2425
Sammy2425 Jun. 29 at 12:21 PM
$ARAY .10 for a pop not a penny more .002-.02
0 · Reply
Flok5000
Flok5000 Jun. 26 at 10:01 PM
$ARAY according to their LinkedIn posts they went live this quarter with at least with 6 new Radixact systems (Romania, Russia, France, Italy, Myanmar, Iran). Seems quite strong
1 · Reply
Sammy2425
Sammy2425 Jun. 26 at 3:50 PM
$ARAY not a penny more then .10 Pinks but should be a pop left
0 · Reply
Sammy2425
Sammy2425 Jun. 26 at 3:08 PM
$ARAY not much sugar after D and E. Suspect we see a sub .20 before Aug. dilution is a bitch
1 · Reply
Sammy2425
Sammy2425 Jun. 26 at 2:33 PM
$ARAY 1-10 pending. 2.00
0 · Reply
goldenmanchurian
goldenmanchurian Jun. 26 at 4:29 AM
$ARAY goddammmit! just sell the company!!! its too much pain holding!!!
1 · Reply
Muddymac
Muddymac Jun. 24 at 3:41 PM
$ARAY Reality check and legitimate Bear thesis: The company now only has 3 sales reps left in the U.S. No clinical support. Service team operating on a shoestring. China’s growth potential and JV has turned into a giant mistake. Highly likely they will not meet their debt covenants and are paying 24%+ on their main loan (look up their interest payments YYD). Almost certainly they will be delisted in August. If you are thinking this is going to turn around, spend a little more time with your DD. Otherwise, good luck. Facts vs feelings.
1 · Reply
raufer12345
raufer12345 Jun. 23 at 4:35 AM
$ARAY r/s incoming then back down to 0.4
0 · Reply
Sammy2425
Sammy2425 Jun. 23 at 3:31 AM
$ARAY 20’s. Buy the .20’s! Gems!
0 · Reply
SpanishTrader07
SpanishTrader07 Jun. 18 at 6:03 PM
$ARAY The deadline for Nasdaq's notification is August 3rd, and the company still hasn't said a word. No plan, no statement, no transparency with shareholders. I really don't like how management is handling this. Investors deserve to know what's going to happen.
1 · Reply
URocka
URocka Jun. 18 at 1:12 PM
$ARAY can the beatdown stop for a little while... some people want to Rock. Let's Rock!
0 · Reply
Mauzi01
Mauzi01 Jun. 18 at 8:41 AM
$ARAY any news, or why that peak ?
0 · Reply
Zskylar
Zskylar Jun. 17 at 5:48 PM
$ARAY more please
0 · Reply